AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.030
-0.110 (-3.50%)
At close: Feb 21, 2025, 4:00 PM
3.070
+0.040 (1.32%)
After-hours: Feb 21, 2025, 7:56 PM EST
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $894.96 million as of February 21, 2025. Its market cap has decreased by -40.46% in one year.
Market Cap
894.96M
Enterprise Value
323.22M
1-Year Change
-40.46%
Ranking
Category
Stock Price
$3.03
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $894.96M, a decrease of -94.29%. That is a compound annual growth rate of -49.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 894.96M | 3.41% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | 10.83B | -30.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |